With the exception of OSCC and CRC, S100A16 was overexpressed in several malignancies, leading to increased proliferation, invasion, and metastasis through a variety of molecular pathways, including PI3K-Akt, MAPK-ERK, JNK/p38, and EMT-signalling. The gene discussed is AKT1; the disease is colorectal carcinoma.